Renal Cancer - Results from #3880

The role of vascular clamping during robot-assisted partial nephrectomy for localised renal cancer: rationale and design of the CLOCK randomised phase III study. January 8, 2019

Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx. January 7, 2019

Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma. January 7, 2019

Position of cytoreductive nephrectomy in the setting of metastatic renal cell carcinoma patients: does the CARMENA trial lead to a paradigm shift? January 7, 2019

HepaCAM regulates Warburg effect of renal cell carcinoma via HIF-1α/ NF-κB signaling pathway. January 4, 2019

Exploratory Investigation of Target Pazopanib Concentration Range for Patients With Renal Cell Carcinoma. January 4, 2019

RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis. January 4, 2019

Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population. January 3, 2019

Renal cell carcinoma presenting as nonspecific gastrointestinal symptoms: a case report. January 3, 2019

Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma. January 3, 2019

Integrated Genomic and Proteomic Analyses Reveal Novel Mechanisms of the Methyltransferase SETD2 in Renal Cell Carcinoma Development. January 2, 2019

Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway. January 2, 2019

Clear cell papillary renal cell carcinoma: A case report and review of the literature. January 2, 2019

Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival. January 2, 2019

Evaluation of a free-breathing respiratory-triggered (Navigator) 3-D T1-weighted (T1W) gradient recalled echo sequence (LAVA) for detection of enhancement in cystic and solid renal masses. January 1, 2019

Trends in the treatment of clinical T1 renal cell carcinoma for octogenarians: Analysis of the National Cancer Database. January 1, 2019

Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib. January 1, 2019

Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab. December 31, 2018

Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions. December 31, 2018

Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database (RECUR). December 31, 2018

Page 195 of 456